Prosecution Insights
Last updated: April 19, 2026
Application No. 17/800,459

MICROARRAYS

Non-Final OA §102
Filed
Aug 17, 2022
Examiner
BOESEN, CHRISTIAN C
Art Unit
1684
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Polymer Forge Inc.
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
3y 8m
To Grant
97%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allow Rate
463 granted / 616 resolved
+15.2% vs TC avg
Strong +22% interview lift
Without
With
+21.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 8m
Avg Prosecution
22 currently pending
Career history
638
Total Applications
across all art units

Statute-Specific Performance

§101
8.5%
-31.5% vs TC avg
§103
28.8%
-11.2% vs TC avg
§102
18.1%
-21.9% vs TC avg
§112
25.4%
-14.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 616 resolved cases

Office Action

§102
3Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION This Non-Final Office Action is responsive to the communication received 10/06/2025. Election/Restrictions Applicant’s election without traverse in the Reply filed on 10/06/2025 of Group II, claims 125-137 is acknowledged. The Restriction Requirements are deemed proper and are made FINAL. Claims 125-137 are pending. Claims 125-137 are under examination in this Office Action. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. Claims 125-137 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Ku et al. (05/30/2019) US Patent Application Publication 2019/0165039 A1 cited in the 12/21/2022 IDS (hereinafter known as "Ku"). With regards to claims 125-137, Ku teaches: a) as in claims 125-137, a method of preparing a microarray comprising steps of: a) providing a micro-LED array light source comprising an integrated substrate, wherein the substrate comprises an array of reaction sites, wherein each reaction site comprises an anchored functional group and is associated with a micro-LED of the array; b) providing a reaction chamber in fluid communication with the array of reaction sites; c) synthesizing a plurality of polymers on the reaction sites by iterative cycles of: i) introducing a light quencher molecule to the reaction chamber; ii) activating the micro-LED associated with one or more of the reaction sites to deprotect the anchored functional group; iii) introducing a subunit comprising a non-anchored functional group protected by a photolabile group to the reaction chamber such that the deprotected anchored functional group binds the subunit and anchors it to the polymer; and iv) removing unbound subunits; wherein the substrate comprises a functional layer to provide the anchored functional group of step a); wherein a linker is bound to the substrate to provide the anchored functional group of step a); wherein a subunit comprising an acid labile group is bound to the substrate and an acid is introduced to the reaction chamber to provide the anchored functional group of step a); wherein the subunits comprise nucleic acids; wherein the photolabile group is NPPOC; wherein the reaction chamber comprises a flow cell apparatus; wherein the number of iterative cycles is at least 10; wherein the method comprises a step of evaluating the micro-LED array light source by activating all pixels of the array and visualizing the array to determine coordinates of functional pixels; wherein the method comprises proceeding with step c) using only reaction sites associated with functional pixels of the micro-LED array light source; wherein the method results in an error rate in the polymers that is reduced relative to a method wherein a light quencher molecule is not introduced to the reaction chamber; wherein the number of sequence errors is less than 10% of the number of errors that occur in a method wherein a light quencher molecule is not introduced to the reaction chamber; wherein the number of sequence errors is less than 1% of the number of errors that occur in a method wherein a light quencher molecule is not introduced to the reaction chamber (see Figures 2A and 2B and [0038] to [0061]). Thus, Ku anticipates the present claims. Conclusion No claim is allowed. Any inquiry concerning this communication or earlier communications from the Examiner should be directed to Christian Boesen whose telephone number is 571-270-1321. The Examiner can normally be reached on Monday-Friday 9:00 AM to 5:00 PM. If attempts to reach the Examiner by telephone are unsuccessful, the Examiner’s supervisor, Heather Calamita can be reached at 571-272-2876. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice . /CHRISTIAN C BOESEN/Primary Examiner, Art Unit 1684
Read full office action

Prosecution Timeline

Aug 17, 2022
Application Filed
Feb 02, 2026
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12601088
DETECTION OF AN ANTIBODY AGAINST A PATHOGEN
2y 5m to grant Granted Apr 14, 2026
Patent 12601089
DIRECT-TO-LIBRARY METHODS, SYSTEMS, AND COMPOSITIONS
2y 5m to grant Granted Apr 14, 2026
Patent 12595591
PEPTIDE LIBRARIES HAVING ENHANCED SUBSEQUENCE DIVERSITY AND METHODS FOR USE THEREOF
2y 5m to grant Granted Apr 07, 2026
Patent 12595592
COMPREHENSIVE MONOCLONAL ANTIBODY GENERATION
2y 5m to grant Granted Apr 07, 2026
Patent 12590386
Recombinant Polyclonal Proteins and Methods of Use Thereof
2y 5m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
97%
With Interview (+21.9%)
3y 8m
Median Time to Grant
Low
PTA Risk
Based on 616 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month